These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37031520)

  • 21. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
    Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
    Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
    Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G
    Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Factors for Bilateral Disease in Papillary Microcarcinoma: A Retrospective Cohort Study.
    Lindner K; Iwen KA; Kußmann J; Fendrich V
    Curr Oncol; 2022 Aug; 29(9):6010-6017. PubMed ID: 36135042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of risk pathological characteristics in clinically low-risk papillary thyroid microcarcinoma suitable for active surveillance.
    Huang H; Liu Y; Ni S; Wang X; Liu S
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1559-1564. PubMed ID: 38153557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
    Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
    Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
    Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
    Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.
    Shou JD; Li FB; Shi LH; Zhou L; Xie L; Wang JB
    Medicine (Baltimore); 2020 Sep; 99(38):e22338. PubMed ID: 32957404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Lobectomy and Total Thyroidectomy in Unilateral Papillary Thyroid Microcarcinoma Patients with Ipsilateral Lateral Lymph Node Metastasis Without Gross Extrathyroidal Extension.
    Song J; Qiu W; Yan T; Wu B; Guo M; Fan Y; Yang Z
    World J Surg; 2020 Aug; 44(8):2677-2684. PubMed ID: 32328782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
    Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
    World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
    Jeon MJ; Kim WG; Kwon H; Kim M; Park S; Oh HS; Han M; Sung TY; Chung KW; Hong SJ; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2017 Jul; 177(1):25-31. PubMed ID: 28432268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supraclavicular Approach of Lobectomy Improves Quality of Life for Patients With Unilateral Papillary Thyroid Microcarcinoma: A Prospective Cohort Study.
    Xue S; Wang Q; Chen G; Wang P; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():766444. PubMed ID: 35058877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for papillary thyroid carcinoma: is lobectomy enough?
    Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.